Sophia Karagiannis

Sophia KaragiannisSophia Karagiannis
SK

Sophia Karagiannis

Professor of Translational Cancer Immunology and Immunotherapy at King's College London

Rate
Advertise here

About

Sophia Karagiannis is a translational cancer immunologist with academic and biotechnology experience in the USA and UK. She leads a cancer antibody discovery team focused on understanding the interplay between patient immune cells and cancer, and on designing novel agents for solid tumors such as melanoma, ovarian, and breast cancers. She is also the founder of Epsilogen Ltd., an immuno-oncology company developing IgE therapeutic agents for cancer.
Frequently asked

Who is Sophia Karagiannis?

Sophia Karagiannis is a translational cancer immunologist with academic and biotechnology experience in the USA and UK. She leads a cancer antibody discovery team focused on understanding the interplay between patient immune cells and cancer, and on designing novel agents for solid tumors such as melanoma, ovarian, and breast cancers. She is also the founder of Epsilogen Ltd., an immuno-oncology c…

What is Sophia Karagiannis's current role?

Sophia Karagiannis is currently Professor of Translational Cancer Immunology and Immunotherapy at King's College London.

Comments

No comments yet. Be the first to share your take.

Profile

About Sophia Karagiannis

Sophia Karagiannis is Professor of Translational Cancer Immunology and Immunotherapy at King's College London. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.